Tumor-infiltrating lymphocyte (TIL) therapy uses the body’s natural immune response to fight cancer. TILs are immune cells that the body makes to attack cancer, and the treatment is now approved for patients with metastatic melanoma.
Here’s how it works: Physicians collect lymphocytes from a patient’s tumor and expand them outside the body until they reach billions in number. Once enough cells are grown, they’re reintroduced into the patient to help control the disease and, in some cases, put it into remission.
Research is ongoing to explore TIL therapy’s potential for treating other cancers, offering new hope for the future of immunotherapy.
If you or someone you know is facing metastatic melanoma, this video offers a clear and hopeful look at what’s possible through the latest in cell therapy.
Learn more about TIL therapy at Northside Hospital Cancer Institute.
